Established in 1995 as the first joint venture investment bank in China, China International Capital Corporation Limited (CICC) is a leader in providing comprehensive financial services including investment banking, capital markets, institutional and individual securities sales and trading, fixed income, asset management, private equity, individual wealth management and research.
ICE Bioscience Inc. is a contract research organization based in Beijing, China, specializing in preclinical research solutions for electrophysiology and early drug discovery services. Founded in 2010, the company focuses on the development of ion channel-related pharmaceuticals, particularly targeting the neuronal and cardiovascular systems. ICE Bioscience offers a range of services, including ion channel profiling, cardiac safety panels, brain slice screening, and various molecular biology applications. The company has established proprietary ion channel cell lines for both voltage-gated and ligand-gated channels. Additionally, it maintains a diverse platform for target-based panel screening, supporting drug discovery across multiple therapeutic areas such as immunology, oncology, and CNS diseases. ICE Bioscience is committed to enhancing the drug discovery process through effective communication and flexible collaboration models, aiming to identify and validate drug targets and streamline the progression from compound screening to preclinical candidate selection.
Astronergy
Series C in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Global Technology
Series C in 2023
Global Technology, headquartered in Shanghai, China, specializes in automotive intelligent driving systems. The company is recognized as a leading supplier in this sector, focusing on advanced electronic active safety products such as Electronic Parking Brakes (EPB), pneumatic and hydraulic Anti-lock Braking Systems (ABS), Electronic Stability Programs (ESP), and Advanced Driver Assistance Systems (ADAS). With a robust emphasis on research and development, Global Technology boasts comprehensive capabilities in vehicle system matching and development. The firm combines design, production, sales, and service functions, supported by a team of senior technical experts in automotive pneumatics, hydraulic brakes, and electronic control. This integration enables the company to provide effective OEM market model matching analysis and forward development capabilities for its clients.
Hydrogen Technology
Venture Round in 2023
Hydrogen Technology focuses on the research and development and industrialization of fuel cell engines. Its main business includes the production and sales of fuel cell engine products and the provision of integrated engineering services for fuel cell vehicles. The company was founded in 2016 and is headquartered in Hangzhou, China.
Vapo Health
Venture Round in 2023
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.
Astronergy
Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Beijing Consen Automation
Venture Round in 2022
Beijing Consen Automation specializes in developing automation control systems for the petrochemical industry and railway signal control systems. The company offers comprehensive solutions aimed at enhancing safety and emergency management within the petrochemical sector. Its primary products include safety operation management systems, safety instrumented systems, and various control systems and control valves. Through these offerings, Beijing Consen Automation enables its clients to improve production safety and operational efficiency in their respective industries.
AIForceTech
Series A in 2022
AIForceTech is a company focused on agricultural robotics and smart machinery, based in Beijing's Haidian District since its founding in 2019. The company develops and manufactures a range of electric-powered agricultural products, including unmanned electric tractors and various robotic solutions. Leveraging artificial intelligence and autonomous driving technology, AIForceTech's equipment is designed to operate unmanned around the clock, significantly enhancing agricultural efficiency. The practical application of its products in real-world scenarios has provided the company with valuable operational insights, driving innovation in the agricultural sector.
Safe Medical Evaluation
Series D in 2022
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
ZSHK Laboratories
Series B in 2022
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.
NewBanker
Series C in 2022
The core founding team of Beijing Niubitou Science and Technology Consulting is composed of senior managers of well-known Chinese wealth management companies and provides information, research, technology, capital and resources for wealth management companies and financial advisers Comprehensive support services.
Sineva
Series C in 2022
Hefei Sineva Intelligent Machine Co., Ltd., established in 2013 and located in Hefei, China, specializes in the research, development, manufacturing, and sales of transfer, test, and service robots. The company operates under the umbrella of Zhejiang Qianjiang Biochemical Co., Ltd. Sineva focuses on providing AI-based machine vision solutions and advanced materials that cater to semiconductor production and drug development. Its business encompasses four main areas: intelligent manufacturing machinery, advanced materials, artificial intelligence, and aircraft. By addressing critical technical gaps in the domestic pan-semiconductor industrial robot sector, Sineva positions itself as a key player in the evolving landscape of intelligent manufacturing.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.
Canhelp Genomics
Series B in 2022
Canhelp Genomics is a prominent healthcare company in China specializing in molecular diagnostics, particularly in oncology. The company aims to enhance patient care by addressing diagnostic uncertainties through reliable and actionable evidence. This approach allows for accurate disease diagnosis and assists physicians in matching patients to personalized treatment options, ultimately improving treatment outcomes in cancer care.
China Resources Vanguard
Funding Round in 2022
China Resources Vanguard, doing business as China Resources Vanguard Shop or Vanguard, operates the supermarket chains of China Resources. It is the third-largest supermarket chain in Hong Kong. As of December 31, 2014, there are 4866 shops operating in Hong Kong and the mainland Chinese provinces/municipalities of Guangdong, Zhejiang, Jiangsu, Shanghai, Tianjin and Beijing. According to market research firm EuroMonitor's estimates in 2012, China Resources Vanguard supermarket market share in Hong Kong is about 7.8%. Wellcome Hong Kong's market share is about 39.8% and PARKnSHOP Hong Kong's market share is about 33.1%. On August 18, 2013, China Resources Enterprise's supermarket chain Vanguard and British supermarket Tesco signed a "memorandum of understanding", intending to set up a joint venture interest group in mainland China, Hong Kong and Macau, operating hypermarkets, supermarkets, convenience stores, liquor stores and cash and carry businesses. China Resources Enterprise took an 80% share and Tesco took a 20% share.
NaaS Technology
Series A in 2022
NaaS Technology is a provider of electric vehicle charging services for operators and owners. The company also offers one-stop services to charging pile manufacturers and operators, OEMs, companies with their delivery fleets, and fleet operators, covering the entire value chain across the EV sector with online, offline, and non-electric services. It had linked 290,000 chargers, with an annual charging capacity of more than 1,200 gigatonnes. NaaS Technology aims to make charging facilities more efficient and to incorporate this into structural changes to China's energy infrastructure, achieving an essential step toward carbon neutrality.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
DST Car
Series D in 2022
Dishangtie is a Shenzhen-based new energy vehicle rental service platform targeting the transportation and logistics industry.
Waytous
Series C in 2022
Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction industries. Founded in November 2014, Waytous develops a cloud-based system that integrates unmanned driving for mining trucks and collaborative operation management for excavators. The company emphasizes the creation of a comprehensive training data and research and development ecosystem to enhance the performance and quality of its intelligent vehicles. Through its innovative technology, Waytous aims to improve operational efficiency and safety in heavy-duty applications.
JYBD
Series B in 2021
JYBD provides a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket. CAB is a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket based on the "industry + internet" model and jointly established by industry channel dealers. Acetin aims to use the Internet to promote the transformation of traditional industries, reduce transaction links, reduce costs, improve industrial efficiency, build a router for the automotive industry, and jointly build a new ecosystem for the automotive aftermarket network. As a platform eco-type Internet enterprise, EPDM has platform service capabilities covering the commercial vehicle + passenger car business group, and On line supply chain + Off line channel operation capabilities, providing service solutions for the entire EPDM industry chain; at the same time as a The service platform for operating 2B & 2C business not only has the ability to integrate offline channels, but also has the full support of many first-class brand supplier groups. Based on the above characteristics, CABNET promotes the Internetization of traditional enterprises, transforms existing businesses with big data, optimizes the supply chain system, reduces costs, improves industrial efficiency, and integrates logistics, capital flow, information flow, business flow, and people flow in a platform-wide industry. The chain is opened, and the scenes of the various after-market transactions in the automotive after-market are presented in a panoramic manner, forming a large ecosystem in which all roles participate together, and eventually becoming an infrastructure platform for the e-commerce transformation of the automotive after-market. Beginning in 2017, the headquarters of EPDM moved to Zhongguancun in Beijing, and the leading companies across the country were formed to form EPDM (Beijing) E-commerce to conduct business nationwide. After years of trial, error correction and accumulation of experience, CABNET has matured its business model. Not only does it have a mature e-commerce system and a well-run model market, it can also have a nationwide offline channel network and a professional operation team. , Has the irreproducible resource advantages of the Chinese tire industry and even the automotive aftermarket. In 2018, the company has successively won tens of millions of CITIC Construction Investment led the Pre-A round, and Manbang Group led the A round of 300 million RMB investment. As of the end of January 2019, it has covered 26 provincial-level administrative regions, 110,000 stores, and 6,200 suppliers. In March, the total monthly platform sales exceeded 500 million yuan, an increase of more than 15% from the previous month, and the annualized transaction volume exceeded 5 billion. yuan. A-People's mission is to "unify the world's stores, so that business is no longer difficult to do"; adhering to the values of customer success and passion; strive to build A-People's Network into an integrated platform for the industry's supply chain, a platform for gathering industry data, and industry standards Output platform. CAB will focus on the automotive aftermarket, unite resources, establish standards, and jointly build a new ecosystem for the automotive aftermarket.
Innoforce Pharmaceuticals
Series A in 2021
Innoforce Pharmaceuticals Co., Ltd is a biopharmaceutical company based in Hangzhou, China, founded in 2018. The company specializes in the development and commercialization of innovative biomedicines, including cell and gene therapies, medicines, and antibodies. Innoforce also operates biologic process development laboratories and offers end-to-end contract development and manufacturing services (CDMO) tailored to support biotech enterprises in their research and development and manufacturing efforts. Through its comprehensive services, Innoforce aids clients in bringing their biopharmaceutical products to market efficiently.
Hua Kong TsingJiao
Series B in 2021
Hua Kong TsingJiao is an IT company established in 2018 and located in Haidian District, Beijing, China. The company specializes in the research, development, and construction of advanced technology centered on modern cryptography and game theory. It has developed a cybersecurity platform that ensures data safety through innovative privacy computing technologies based on multi-party secure computing. This allows multiple non-mutually trusted databases to perform efficient data fusion while maintaining the confidentiality of the data involved. Additionally, its computing platform supports general computing tasks and is compatible with popular libraries like NumPy and PyTorch, thereby simplifying the use of ciphertext calculations for users.
VisionNav Robotics
Series C in 2021
VisionNav Robotics Limited specializes in the design, development, and manufacturing of autonomous industrial vehicles and solutions for intralogistics automation. Founded in 2015 and based in Shenzhen, China, the company utilizes advanced technologies such as artificial intelligence, environmental perception, deep learning, and servo control to create a range of products, including unmanned forklifts and tractors. VisionNav offers a variety of automated vehicles tailored for both indoor and outdoor environments, addressing the needs of sectors such as e-commerce logistics, aviation logistics, and retail. The company has achieved notable advancements in material storage and navigation capabilities, enabling efficient operations in narrow spaces and complex logistics scenarios. With a strong portfolio of projects across over 50 companies in diverse industries, VisionNav Robotics is committed to enhancing global logistics efficiency through innovative driverless solutions.
MediTrust Health
Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a beneficial ecosystem for all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust delivers economical, personalized healthcare solutions to families. Additionally, it addresses medical payment challenges by providing services that help manage medical expenses and improve financial accessibility for patients. Through its diverse offerings, MediTrust aims to enhance the overall healthcare experience while ensuring that patients receive effective medical care and support.
CalmCar Vision System
Series C in 2021
CalmCar Vehicle Vision is a Chinese intelligent driving vision system provider. They are specialized in developing intelligent vision system for ADAS, autopilot and autonomous driving with functions of Lane Departure Warning (LDW), Front Collision Warning (FCW), Pedestrian Collision Warning(PCW), Blind Spot Detection (BSD) and Traffic Sign Recognition (TSR).
Leyan Technologies
Series D in 2021
Leyan Technologies is an artificial intelligence company based in Shanghai, China, founded in April 2016. It specializes in developing digital solutions for the robotics industry, focusing on an AI technology platform that enhances human-computer interaction. The company offers intelligent customer service robots and applies its AI technologies across various sectors, including e-commerce, financial consulting, and medical consultation. Leyan Technologies aims to improve customer experiences and streamline service delivery through its innovative solutions.
Xreal
Series B in 2021
Xreal is a developer of mixed reality technology based in Beijing, China, founded in 2017. The company specializes in creating lightweight mixed reality glasses, with its flagship product, Nreal Light, designed for comfort and vivid display quality. These glasses utilize advanced spatial computing algorithms and environment-understanding AI to deliver an immersive user experience. Xreal aims to make mixed reality technology accessible to a broader audience, while also empowering developers to create innovative applications that enhance entertainment and productivity. Through its products and initiatives, Xreal seeks to unlock the full potential of mixed reality in everyday life.
Ascentawits
Series A in 2021
Ascentawits Pharmaceuticals Ltd. is a biotechnology company established in 2014 and located in Shenzhen, China. The company specializes in the development of anti-tumor drugs, focusing on small molecule targeted conjugated therapies. Ascentawits employs innovative drug designs and screening methods that leverage specific tumor micro-environments to create effective treatments for cancer patients. Through its research and development efforts, the firm aims to provide advanced therapeutic options that address the needs of those affected by cancer.
Miaoshou Doctor
Series E in 2021
Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors. It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions. Tao He and Daoliang Han founded the company in 2015 and is based in Beijing, Beijing.
Dobot
Venture Round in 2021
Dobot is a leading robotic arm solutions provider in China which makes technology simple and fun, easy to use and endless possibility. Together we make the world different, from the first desktop robotic arm to STEAM robot kit, Dobot never stops.
WeRide
Series B in 2021
WeRide is a leading, commercial-stage global company that develops Level 4 autonomous driving technologies. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable and accessible. WeRide is conducting autonomous driving R&D, tests and operations in over 25 cities around the world. As the pioneer leader in autonomous technologies and services, WeRide has stepped up to the commercial stage in operations. WeRide offers an all-rounded product mix of Robotaxi, Robobus, Robovan, Robosweeper and ADAS, providing smart services in online ride-hailing, on-demand transport, urban logistics, sanitation services and acting as a solution provider. Established in 2017, WeRide is headquartered in Guangzhou, China, and has expanded its R&D and operation centers to Beijing, Shanghai, Shenzhen, Zhengzhou, Nanjing, Wuhan, and Anqing, as well as San Francisco in the US. WeRide has formed strategic partnerships with leading global OEMs and Tier 1 supplier including Renault-Nissan-Mitsubishi Alliance, Yutong Group, GAC Group, Bosch, etc.
Core Medical Technology
Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Singlera Genomics
Series B in 2020
Singlera Genomics Inc. specializes in genetic testing and molecular diagnostic technologies, focusing on non-invasive solutions for cancer screening and diagnosis. The company has developed a methylation detection platform that aids in early tumor detection and cancer prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. Founded in 2014 and based in La Jolla, California, Singlera also operates research and development centers in Shanghai, China, and is committed to advancing precision medicine to provide patients with early, accurate, and informative diagnoses.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
SequoiaDB
Series D in 2020
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, established in 2011. It offers a range of products, including SequoiaDB, an enterprise-class distributed relational database designed for online transactions, data centers, and content management applications, as well as SequoiaCM, a solution for managing unstructured data in large and medium-sized enterprises. The company provides services in online transaction processing, content management, and data lake solutions, primarily catering to financial institutions such as banks, insurance firms, and securities companies. SequoiaDB is committed to research and development, aiming to become a global leader in the database industry, and has been recognized in Gartner's reports for its innovative database systems.
LinkDoc
Series D in 2020
LinkDoc Technology Limited, founded in 2014 and headquartered in Beijing, China, specializes in medical data solutions and oncology-focused big data platforms. The company provides structured clinical data to oncology hospitals, aiding them in addressing various scientific and clinical challenges. Additionally, LinkDoc is committed to ensuring patient privacy and data security, adhering to standards set by the US HIPAA Act. The company focuses on delivering continuous care for patients with critical diseases and offers data-driven solutions that support life sciences companies and healthcare professionals in enhancing clinical research and facilitating real-world application of medical advancements.
Thousand Oaks Biopharmaceuticals
Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and located in Haimen, China, specializes in contract development and manufacturing services tailored for the biotechnology sector. The company focuses on developing biopharmaceutical technologies aimed at producing protein and vaccine compounds. It offers integrated control solutions that enhance production processes by optimizing protein expression and reducing production scale. This enables biopharmaceutical companies to access personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services. By providing these comprehensive services, Thousand Oaks Biopharmaceuticals aims to facilitate the creation of accessible and affordable biologics to meet global healthcare needs.
Missfresh
Series E in 2020
Beijing Missfresh E-Commerce Co., Ltd. is a Chinese e-commerce platform focused on grocery delivery, specializing in high-quality fresh food. Founded in November 2014 and based in Beijing, the company operates a mobile application that allows consumers to purchase a wide variety of products, including fruits, vegetables, dairy, meat, seafood, snacks, and beverages. Missfresh delivers these items directly to customers' doorsteps through its network of delivery riders. The company serves 20 cities across China and integrates its services with third-party social platforms to enhance user accessibility. Its business model combines online and offline retail, catering to the growing demand for convenient and fresh grocery shopping solutions.
Yellow Swan
Series A in 2020
Yellow Swan Edible Fresh Eggs is a domestic enterprise based in Chengdu, Sichuan, China, specializing in the production and retail of bacteria-free eggs. Founded in 2018, the company focuses on providing raw-edible eggs that are free from Salmonella, ensuring higher food safety and quality for consumers. Through its commitment to health standards, Yellow Swan aims to enhance the culinary experience by offering a product that allows for safer consumption of raw eggs.
Mabworks
Series C in 2020
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
Suzhou Ribo Life Science
Series C in 2020
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Abbisko Therapeutics
Series C in 2020
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Lansus Technologies
Series B in 2019
Lansus Technologies Inc. is a fabless semiconductor company based in Shenzhen, China, with a research center in Shanghai. Founded in 2015, the company specializes in developing advanced chip solutions, particularly in radio frequency power amplifiers, switches, and radio-frequency front-end modules. Lansus Technologies provides industrial clients with power amplification solutions utilizing wireless RF devices and systems, catering to sectors such as mobile communications, IoT home furnishings, and industrial electronics. The company focuses on delivering 5G and 4G wireless solutions, promoting technological progress in the radio frequency field while emphasizing sustainable development.
Transwarp
Series D in 2019
Transwarp develops big data software technologies for enterprises. The company's cloud-based platform offers an integrated, one-stop data processing and cloud operating system to explore the applications of big data infrastructure in enterprises, enabling enterprises to store, manage and analyze data.
X-Giants
Series A in 2019
X-Giants is a human resources solution provider based in Shanghai, China, founded in 2005. The company specializes in recruitment solutions, offering a range of services that include talent search, recruitment process outsourcing, flexible employment, and personnel outsourcing. In addition to these core services, X-Giants provides consulting and training, as well as salary and benefits management. The company also engages in innovative initiatives, exemplified by its organization of the "blockchain+human resources ecological alliance" launch ceremony, which highlights its commitment to integrating advanced technologies within the HR sector.
JD Logistics
Series A in 2019
JD Logistics, a subsidiary of JD.com, operates as a technology-driven supply chain solutions and logistics service provider in China. Established in 2007, JD Logistics focuses on creating efficient and sustainable logistics solutions, encompassing a wide range of services from warehousing to distribution. The company serves various industries, including fast-moving consumer goods, apparel, home appliances, consumer electronics, automotive, and fresh produce. JD Logistics is committed to formulating and executing tailored supply chain strategies to meet the diverse needs of its clients. Its mission is to become the world's most reliable supply chain infrastructure service provider, leveraging technology to enhance operational efficiency.
Unisound
Series D in 2019
Beijing Yunzhisheng Information Technology Co., Ltd. specializes in intelligent voice and speech processing technologies. Founded in June 2012, the company has developed proprietary speech recognition technologies and offers middleware and cloud platforms that deliver professional speech recognition services to internet enterprises and users. Its core technology encompasses voice technology, language technology, knowledge computing, and big data analysis, facilitating efficient communication between customers and machines. The company's technology team is highly qualified, with over 80% of its members holding doctoral degrees and possessing more than a decade of experience in voice recognition research and development. By leveraging cloud computing and mobile internet technologies, Yunzhisheng aims to enhance user interaction with devices, minimizing the need for manual input.
Abbisko Therapeutics
Series B in 2019
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Jusda
Series A in 2019
Jusda International Supply Chain Management Co., Ltd., founded in 2000 and based in Shenzhen, China, specializes in providing a comprehensive service platform for supply chain management. The company offers a range of freight and logistics services, including e-commerce supply chain solutions, aimed at enhancing efficiency in global trade. As a key service provider for Foxconn Technology Group, Jusda focuses on integrating Component to Consumer (C2C) supply chain services. The firm's innovative business model encompasses various flows—trading, goods, information, capital, technology, and process—leveraging advanced technology and research and development to drive professionalism and growth within the supply chain management sector.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.
Tuhu
Series E in 2018
Tuhu is a prominent integrated online and offline platform for automotive services in China, catering to car owners' diverse needs. Operating in over 260 cities, Tuhu offers same-day or next-day delivery and installation services for automobile after-sales products. The company utilizes its website, mobile app, call center, and third-party e-commerce platforms to deliver a digitalized and on-demand service experience. Tuhu's platform addresses a wide range of automotive service demands, including the replacement of tires and chassis parts, as well as auto maintenance, repair, and detailing. By connecting car owners with suppliers and automotive service stores, Tuhu effectively fulfills the requirements of most passenger vehicle models sold in China.
Makeblock
Series C in 2018
Makeblock provides a do-it-yourself (DIY) robotics construction and programming learning platform designed to develop modular and programmable starter drone. Its DIY robotics construction and programming learning platform offer mechanical parts, multiple electronic modules and graphical programming software, enabling STEM learners, educators and hobbyists to construct robots that can be turned into a hovercraft, car and more. Jasen Wang founded Makeblock in 2013. Its headquarters is in Shenzhen in China.
Shanghai Henlius Biotech
Venture Round in 2018
Shanghai Henlius Biotech, Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the research, development, production, and commercialization of biologics, particularly monoclonal antibody (mAb) biosimilars and novel therapies. Founded in 2010, the company focuses on oncology and autoimmune diseases, offering products such as HLX01, a biosimilar for treating non-Hodgkin lymphoma. Henlius is actively advancing its pipeline, with multiple products under review for regulatory approval, alongside conducting numerous clinical studies for various therapies. The company collaborates with partners, including agreements to develop treatments for COVID-19 and eye diseases. Shanghai Henlius Biotech is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, established in 2009, and operates out of the Shanghai Caohejing High-Technology Park.
Xpeng Motors
Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Zing Home
Corporate Round in 2017
Zing Home is a Shenzhen-based household products and furniture retail brand. It currently operates in 46 cities across China with over 160 offline stores.
Gaosi Education Group
Series C in 2017
Gaosi Education Group is a Chinese educational and training institution. It is a domestic extracurricular tutorial institution that provides services for middle and primary schools. Gaosi Education Group offers courses for gifted children from primary school to junior high school. It has set up personalized one-to-one teaching centers, where mathematics competitions for primary, secondary, and high schools are one of the featured courses. Gaosi currently has nearly 10,000 students and 100 full-time teachers and personnel of teaching and researching teams. The institution was founded in December 2009 and is headquartered in Gaosi Education Building, Wudaokou, Haidian District, Beijing.
United Imaging Healthcare
Series A in 2017
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products, radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen.
Distinct HealthCare
Series C in 2017
Distinct Healthcare operates a network of private healthcare clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company provides a range of medical services, including pediatrics, internal medicine, gynecology, and family medicine. Their offerings cover common health issues such as colds, headaches, diabetes, and chronic kidney disease, as well as emergency support and referrals to specialists. Distinct Healthcare also conducts various examinations and laboratory tests, including imaging and blood tests, in collaboration with affiliated hospitals. The company emphasizes patient-oriented care and strives to minimize unnecessary antibiotic prescriptions and excessive examinations, ensuring quality medical services through experienced medical professionals. Additionally, Distinct Healthcare offers nursing services and well baby plans, enhancing comprehensive healthcare for families. The company has established a strategic partnership with Tencent Holdings Limited to further enhance its services.
SenseTime
Series B in 2017
SenseTime Group Limited is an artificial intelligence company specializing in computer vision and deep learning technologies. Founded in 2014 and headquartered in Beijing, China, the company develops a wide range of AI solutions, including face and body analysis, image and video recognition, autonomous driving technologies, and medical image analysis. SenseTime's proprietary AI infrastructure, SenseCore, supports scalable and efficient AI software platforms tailored for various applications across sectors such as smart cities, intelligent transportation, healthcare, and finance. The company is also active in advancing industry standards related to data security and ethical AI practices, having contributed to numerous national and international guidelines. With a presence in multiple countries, including Japan, Singapore, and several locations in China, SenseTime aims to drive innovation and foster sustainable productivity through its AI technologies.
QingCloud
Series D in 2017
QingCloud is a cloud computing platform that provides IaaS-based flexible cloud services, and supporting private network, calculation based on second, open API, comprehensive monitoring, and multiple real time copy security policy. QingCloud is a newly established company in China by Spencer, Reno, and Richard, who previously work for Tencent, Baidu, and IBM. They wanted to learn from the AWS idea, and create a more optimized IaaS-based platform with real significance in the technological level. Richard, the CEO of QingCloud, expressed in an interview with CSDN that Qingcloud aims to be a world level cloud platform. According to their plan, the construction work in Asia Pacific area will be initiated next year, expanding their business overseas.
UCloud Information Technology
Series D in 2017
UCloud Information Technology provides IaaS (base cloud computing), independent research and development, computational resource, storage resource, network resource, and other basic IT infrastructure services. It offers UCloud Physical Host that provides physical servers, UCloud Host, a UCloud-based mature cloud computing technology, UCloud Load Balancer, a load balancing service that offers automatic allocation of application data among multiple cloud hosts, UCloud Network, a UCloud network service that manages network resources, and UCloud Extended Hybrid Cloud that offers a hybrid deployment service of cloud platforms and server hosting. UCloud Information Technology also provides UCloud Disk that provides permanent hard disk storage space for cloud hosting, UCloud DataBase, a data base service based on mature cloud computing technology, UCloud Memory Storage, a key-value memory database, UCloud Content Delivery Network services, Object Storage that provides unstructured file storage services for Internet applications, UCloud Distributed Data Processing solutions, Cloud Security that provides testing services, and scheduling interface solutions for cloud computing resources. It serves video, O2O and E-Commerce, Internet finance, PaaS/SaaS, game, mobile SNS, online education, and digital marketing sectors. Ji Xinhua, Hua Kun, and Mo Xianfeng founded UCloud Information Technology in 2011. Its headquarters is in Shanghai in China.
Lachesis
Series A in 2017
Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications and intelligent products for healthcare providers, including doctors, nurses, patients, and hospitals. The company offers a range of solutions, such as bedside nursing tools, interactive smart ward systems, and an IoT platform designed to enhance medical care. By leveraging information and communications technology, Lachesis delivers mobile medical hardware, application software, and comprehensive solutions aimed at improving management efficiency and assessment accuracy in healthcare settings.
UCAR Technology
Series C in 2016
UCAR Technology, established in 2015 and headquartered in Tianjin, China, is a prominent provider of chauffeured car services. The company operates an on-demand car-hailing platform that connects customers with local licensed drivers through their smartphones. UCAR combines mobile internet technology, big data, and a fleet of quality rental vehicles to ensure safe and standardized transportation. The company's services include both chauffeured car options and vehicle rentals, with a focus on driver qualifications and vehicle conditions. UCAR employs advanced technologies to monitor driver behavior, ensuring privacy protection and efficient response to accidents, thereby enhancing the overall customer experience.
Bairong
Series B in 2016
Bairong is an independent technology platform based in China that offers professional financial information services primarily to large companies in the financial services industry. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong focuses on exploring innovative applications that enhance the digital transformation of financial institutions. The company aims to empower these institutions to innovate while also promoting financial inclusion. Through its AI-driven solutions, Bairong supports financial organizations in navigating the evolving landscape of technology in finance.
Daoyoudao
Post in 2015
Daoyoudao is a Beijing-based technology company that specializes in providing digital marketing services aimed at user growth. Serving clients across various sectors, including internet, education, and automotive industries, the company focuses on acquiring new users through digital effect marketing. Additionally, Daoyoudao enhances user engagement by utilizing programmatic content strategies. Their expertise encompasses information flow advertising and short video advertising, enabling clients to effectively reach and activate their target audiences.
Wacai.com
Series B in 2015
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
Zhong An
Series A in 2015
Zhong An Online is a Chinese property insurance company that sells all its products online along with handling claims. The company offers e-commerce, mobile payment, and financing guarantee for internet businesses and users. Founded in 2013, Zhong An Online offers business opportunities covering various areas, including the internet-based business and household property insurance, cargo insurance, liability insurance, and credit insurance.
Lufax
Series A in 2015
Lufax is a technology-driven personal financial services platform based in China and associated with Ping An Insurance. The company specializes in providing a range of financial services, including wealth management and retail credit facilitation. It offers investment services tailored for institutions and individual investors, focusing on financial asset transactions and transaction financing consulting. Additionally, Lufax provides services related to financial asset allocation and manages a platform for facilitating these transactions, thereby enhancing the efficiency of financial operations for its clients.
Chunyu Yisheng
Series C in 2014
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other. The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatment services to its users. Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing.
New China Life Insurance
Venture Round in 2011
New China Life Insurance Co., Ltd. (新华保险) is a large Chinese insurance company offering traditional security and new-type life insurance products Founded in September 1996, New China Life Insurance has developed various products which can meet the security requirements of customers in terms of accidental injury, medical treatment, endowment, children's education, family finance, and more. In addition, it has an institution network covering almost all provinces, cities, autonomous regions, and diversified sales channels. The company constantly ranks first in the countrywide market of life insurance, and has regarded risk control as important as business development. It has also built a comprehensive risk management system of "horizontal to the edge and vertical to the end" to protect the interest of all parties with the help of a global consulting company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.